BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1720
-0.0080 (-4.44%)
Mar 5, 2026, 1:40 PM EST

BioLargo Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7.7717.7812.235.882.53
Revenue Growth (YoY)
-56.33%45.37%107.85%132.48%4.07%
Cost of Revenue
4.369.936.083.031.43
Gross Profit
3.417.856.152.861.1
Selling, General & Admin
11.779.38.066.736.17
Research & Development
2.592.882.281.321.37
Other Operating Expenses
--0.01-0.06-0.02
Operating Expenses
18.2512.1810.357.997.52
Operating Income
-14.84-4.33-4.2-5.13-6.42
Interest Expense
-0.54-0.03-0.09-0.05-0.23
Interest & Investment Income
0.2----
Other Non Operating Income (Expenses)
0.01-0.080.040.070.06
EBT Excluding Unusual Items
-15.18-4.44-4.25-5.11-6.6
Asset Writedown
-0.01--0.39-0.2-0.34
Other Unusual Items
-0.1-0.170.04
Pretax Income
-15.19-4.35-4.65-5.13-6.89
Earnings From Continuing Operations
-15.19-4.35-4.65-5.13-6.89
Minority Interest in Earnings
3.411.951.140.66-0.19
Net Income
-11.78-2.4-3.5-4.47-7.08
Net Income to Common
-11.78-2.4-3.5-4.47-7.08
Shares Outstanding (Basic)
307298286268247
Shares Outstanding (Diluted)
307298286268247
Shares Change (YoY)
2.96%4.25%6.58%8.54%26.13%
EPS (Basic)
-0.04-0.01-0.01-0.02-0.03
EPS (Diluted)
-0.04-0.01-0.01-0.02-0.03
Free Cash Flow
-8.34-4.44-2.84-3.03-3.96
Free Cash Flow Per Share
-0.03-0.01-0.01-0.01-0.02
Gross Margin
43.86%44.17%50.32%48.55%43.58%
Operating Margin
-191.13%-24.36%-34.33%-87.19%-253.50%
Profit Margin
-151.71%-13.51%-28.65%-76.02%-279.73%
Free Cash Flow Margin
-107.44%-24.98%-23.25%-51.55%-156.38%
EBITDA
-14.7-4.18-4.1-5.09-6.4
EBITDA Margin
-189.26%-23.49%-33.49%-86.42%-252.71%
D&A For EBITDA
0.150.160.10.050.02
EBIT
-14.84-4.33-4.2-5.13-6.42
EBIT Margin
-191.13%-24.36%-34.33%-87.19%-253.50%
Revenue as Reported
7.7717.7812.235.882.53
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.